{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:40:40Z","timestamp":1780461640701,"version":"3.54.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The molecular mechanisms for uveal ring melanoma are still unclear until today. In this case report, we describe a patient with a malignant uveal melanoma with exudative retinal detachment that had been treated with plaque brachytherapy, resulting in successful tumor regression. After 1 year, a ring-shaped recurrence with extraocular extension appeared, and the eye required enucleation. Histological and molecular genetic analyses revealed an epithelioid-cell-type melanoma with complete circumferential involvement of the ciliary body and, so far, unreported GNAQ and SF3B1 mutations in ring melanoma. Therefore, this report gives new genetic background information on this ocular tumor usually leading to enucleation.<\/jats:p>","DOI":"10.3389\/fonc.2022.873252","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T09:39:53Z","timestamp":1653471593000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: GNAQ- and SF3B1 Mutations in an Aggressive Case of Relapsing Uveal Ring Melanoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Michelle","family":"Prasuhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine Christin","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"L\u00fcken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinodh","family":"Kakkassery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Merz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almuth","family":"Caliebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Spielmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdy","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Rommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3892\/etm.2021.10863","article-title":"Uveal Melanoma Diagnosis and Current Treatment Options (Review)","volume":"22","author":"Branisteanu","year":"2021","journal-title":"Exp Ther Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/00006982-200212000-00003","article-title":"Ring Melanoma of the Ciliary Body: Report on Twenty-Three Patients","volume":"22","author":"Demirci","year":"2002","journal-title":"Retina"},{"key":"B3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/BF01994790","article-title":"Weitere Studien Uber Intraoculare Sarkome. III. Flachensarkome Des Uvealtractus","volume":"45","author":"Ewetzky","year":"1898","journal-title":"Von Graefes Arch Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ajo.2012.06.026","article-title":"Intravitreal Triamcinolone Versus Intravitreal Bevacizumab in the Treatment of Exudative Retinal Detachment Secondary to Posterior Uveal Melanoma","volume":"155","author":"Parrozzani","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"B5","first-page":"697","article-title":"Ring Recurrence of Ciliary Body Melanoma After Proton-Beam Therapy","volume":"20","author":"Meyer","year":"1997","journal-title":"J Fr Ophtalmol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2009.02069.x","article-title":"Recurrence of Treated Ciliary Body Melanoma Following Trabeculectomy","volume":"37","author":"Tay","year":"2009","journal-title":"Clin Exp Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(89)32738-2","article-title":"The Risk of Enucleation After Proton Beam Irradiation of Uveal Melanoma","volume":"96","author":"Egan","year":"1989","journal-title":"Ophthalmology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.81.9.748","article-title":"Predictive Factors for the Development of Rubeosis Following Proton Beam Radiotherapy for Uveal\u00a0Melanoma","volume":"81","author":"Foss","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3892\/ijo.2021.5190","article-title":"Current Molecular and Clinical Insights Into Uveal Melanoma (Review)","volume":"58","author":"Fallico","year":"2021","journal-title":"Int J Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/0301-4738.154367","article-title":"Uveal Melanoma: Estimating Prognosis","volume":"63","author":"Kaliki","year":"2015","journal-title":"Indian J Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic Implications of Monosomy 3 in Uveal Melanoma","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5858\/133.8.1219","article-title":"Variation of Monosomy 3 Status Within Uveal Melanoma","volume":"133","author":"Schoenfield","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.3390\/cancers13215503","article-title":"Genetic Landscape and Emerging Therapies in Uveal Melanoma","volume":"13","author":"Seedor","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B14","article-title":"Detection of C-Myc Amplification in Uveal Melanoma by Fluorescent In Situ Hybridization","volume":"42","author":"Parrella","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in Uveal Melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11071019","article-title":"Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology","volume":"11","author":"Vivet-Noguer","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B17","first-page":"5749","article-title":"Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma","volume-title":"Cancers (Basel)","author":"Terai","year":"2021"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2523","article-title":"Recurrent Mutations at Codon 625 of the Splicing Factor SF3B1 in Uveal Melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1159\/000502888","article-title":"Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal Melanoma in Chinese Patients","volume":"63","author":"Hou","year":"2020","journal-title":"Ophthalmic Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.609409","article-title":"The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer","volume":"10","author":"Leeksma","year":"2020","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2021-1137","article-title":"Abstract 1137: PRMT5 Inhibition Regulates Alternative Splicing and DNA Damage Repair Pathways in SF3B1 R625G Expressing Uveal Melanoma Cells","volume":"81","author":"Hamard","year":"2021","journal-title":"Cancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.873252\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T09:39:58Z","timestamp":1653471598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.873252\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":21,"alternative-id":["10.3389\/fonc.2022.873252"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.873252","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"article-number":"873252"}}